|
ZNF593 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.407930E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.723300E-03 |
| Normal-vs-Stage2 |
7.720300E-03 |
| Normal-vs-Stage3 |
4.202500E-04 |
| Normal-vs-Stage4 |
5.158900E-03 |
| Stage1-vs-Stage2 |
2.972800E-01 |
| Stage1-vs-Stage3 |
2.876400E-01 |
| Stage1-vs-Stage4 |
7.847800E-01 |
| Stage2-vs-Stage3 |
6.450000E-01 |
| Stage2-vs-Stage4 |
2.596200E-01 |
| Stage3-vs-Stage4 |
2.680200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.964200E-04 |
| Normal-vs-AfricanAmerican |
9.315600E-02 |
| Normal-vs-Asian |
1.371200E-01 |
| Caucasian-vs-AfricanAmerican |
4.855200E-01 |
| Caucasian-vs-Asian |
6.350400E-02 |
| AfricanAmerican-vs-Asian |
6.374400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.992700E-04 |
| Normal-vs-Female |
3.554300E-04 |
| Male-vs-Female |
5.130600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.981400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.944530E-03 |
| Normal-vs-Age(61-80Yrs) |
9.572900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.944300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.029600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.052600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.983500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.549000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.789700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.682430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.768400E-01 |
| Classical-VS-Follicular |
2.145600E-02 |
| Classical-VS-Other |
7.175200E-01 |
| Classical-VS-Normal |
9.699500E-03 |
| Tall-VS-Follicular |
3.065600E-01 |
| Tall-VS-Other |
8.353800E-01 |
| Tall-VS-Normal |
8.406500E-02 |
| Follicular-VS-Other |
4.218200E-01 |
| Follicular-VS-Normal |
9.86299999999884E-05 |
| Other-VS-Normal |
1.172620E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.36019999999959E-05 |
| Normal-vs-N1 |
4.755000E-03 |
| N0-vs-N1 |
8.565600E-01 |
|
|
